A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain

NCT01619150 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Etoricoxib, followed by placebo (matching tablet, without active ingredient)
DRUG: Placebo (matching tablet, without active ingredient), followed by etoricoxib

Sponsor

C4Pain

Collaborators

[object Object]